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Abstract
Oxygen is a vital requirement for multi-cellular organisms to generate energy and cells have developed multiple
compensatory mechanisms to adapt to stressful hypoxic conditions. Such adaptive mechanisms are intricately
interconnected with other signaling pathways that regulate cellular functions such as cell growth. However, our
understanding of the overall system governing the cellular response to the availability of oxygen remains limited. To
identify new genes involved in the response to hypoxic stress, we have performed a genome-wide gene knockdown
analysis in human lung carcinoma PC8 cells using an shRNA library carried by a lentiviral vector. The knockdown analysis
was performed under both normoxic and hypoxic conditions to identify shRNA sequences enriched or lost in the resulting
selected cell populations. Consequently, we identified 56 candidate genes that might contribute to the cellular response to
hypoxia. Subsequent individual knockdown of each gene demonstrated that 13 of these have a significant effect upon
oxygen-sensitive cell growth. The identification of BCL2L1, which encodes a Bcl-2 family protein that plays a role in cell
survival by preventing apoptosis, validates the successful design of our screen. The other selected genes have not
previously been directly implicated in the cellular response to hypoxia. Interestingly, hypoxia did not directly enhance the
expression of any of the identified genes, suggesting that we have identified a new class of genes that have been missed by
conventional gene expression analyses to identify hypoxia response genes. Thus, our genetic screening method using
a genome-wide shRNA library and the newly-identified genes represent useful tools to analyze the cellular systems that
respond to hypoxic stress.
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Introduction
Most eukaryotic cells make use of oxidative phosphorylation
(OXPHOS) in the mitochondria for the production of ATP during
normoxia. When the oxygen supply becomes insufficient,
OXPHOS becomes inefficient and the cell makes use of glycolysis
to compensate for this insufficiency. Hypoxia is common in tumor
tissues in which the glycolytic activity is usually markedly increased
relative to the surrounding non-tumor tissue. This phenomenon
can be exploited as a means of early detection of small cancerous
nodules by marking the latter specifically with
18F-fluorodeoxy
glucose, followed by detection of the labeled cells in patients using
positron emission tomography (PET) [1,2]. The transcription
factor Hypoxia Inducible Factor-1 (HIF-1) plays a major role in
switching ATP production from OXPHOS to glycolysis under
hypoxic conditions. In most cells, HIF-1 is inhibited by oxygen
sensor proteins, such as HIF prolyl-hydroxylases (PHDs) and
Factor Inhibiting HIF-1 (FIH-1) under oxygen-rich conditions [3–
5]. On the other hand, malignant tumor cells are also known to
make use of glycolysis for energy production even during
normoxia and this phenomenon is known as the Warburg Effect
[6]. Although many genes, such as p53, mTOR, Ras, and Myc,
have been implicated in the development of the Warburg effect,
HIF-1 is the major player [5,7,8].We have studied MT1-MMP,
a membrane type matrix metalloprotease (MMP), that promotes
cancer cell invasion and growth in a collagen-rich tissue
environment via its proteolytic activity. During the course of that
study, we also observed that the cytoplasmic tail of MT1-MMP
stimulates HIF-1 activity independently from the protease activity
and thereby contributes to the Warburg Effect [8–10]. It was
surprising to us that this membrane protease had an unexpected
new function to activate HIF-1. Based on the discovery of the new
link between HIF-1 and MT1-MMP, we became interested in the
molecular links between different cellular regulatory mechanisms
that control the response of cells to hypoxia. Cross talk between
these signaling pathways is presumably important for cells to adapt
to hypoxic stress in a manner that is coordinated with the
regulation of other cellular processes. Activation or inhibition of
such connections in cancer cells may benefit cell survival and
proliferation.
Some cancer cells survive and even grow under hypoxic
conditions that would lead to apoptosis of normal cells. Cancer
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of anti-apoptotic proteins such as Bcl-2 and Bcl-xL [11]. In
addition, enhanced signaling through Ras, Akt, and mTOR also
contributes to the survival and growth of cancer cells during
hypoxia [12–14]. At the same time, cancer cells tend to adopt
a power saving growth strategy by suppressing the transcription
and translation of unessential genes. Therefore, it is possible that
RNA-protein complexes such as stress granules and processing
bodies (P-bodies) regulate the translation of transcripts during
hypoxia [15–17]. Abnormal proteins generated during translation
collect in the endoplasmic reticulum under stressful conditions,
such as hypoxia and low nutrient availability. Because the
accumulation of excessive levels of such unfolded proteins
provokes apoptosis, the appropriate translation and folding/
sorting of proteins is expected to be required for cell survival
and growth during hypoxia [14].
Since diverse cell functions involving many genes are expected
to play roles in cell survival and growth during hypoxia, the
cellular responses to hypoxia have been studied extensively.
Nevertheless, our understanding of the regulation of cellular
responses to hypoxic stress is still fragmentary. This may be
because most previous studied have focused on genes whose
expression is induced during hypoxia [18–20]. To identify new
genes involved in the cellular response to hypoxia and its affect
upon cell growth, we performed a genetic screen using an shRNA
library that covers forty thousand genes. We transduced the
shRNA sequences into recipient cells with a lentiviral vector and
the cells were selected by growing during either hypoxia or
normoxia. The relative abundance of individual shRNA sequences
in the selected cell populations presumably reflects the contribu-
tion of the target genes of the shRNA sequences to cell growth in
an oxygen-sensitive manner.
In this study, we identified 56 such genes, 13 of which were
indeed confirmed to modulate cell growth in an oxygen-dependent
manner. These genes include BCL2L1, whose product is known to
play a role in cell survival during hypoxia [21,22]. However, the
functions of the other 12 genes have yet to be implicated in the
hypoxic response.
Results
A genome-wide shRNA-based screen for genes that
contribute to the cellular response to hypoxia
We performed a genome wide RNAi-based loss-of-function
genetic screen using the Lentivirus GeneNet
TM Human 50 K
shRNA Library. The library comprises a collection of lentiviral
vectors carrying 200,000 short-hairpin RNAs (shRNAs), each
targeting one of 38,500 genes. The shRNA sequences were
designed to be amplified in vitro so as to allow their analysis by
hybridization to Affymetrix GeneChipH Arrays to estimate their
relative abundance in the cells. We transduced the library into
human lung adenocarcinoma PC8 cells, which were the most
permissive among the cancer cell lines tested for transduction by
the lentiviral vector. The cells were then cultured under normoxia
(21% O2) or hypoxia (1% O2) until the 10
th passage. The shRNA
sequences present in the selected cells at that time were then
amplified by PCR following reverse transcription (RT-PCR), and
the relative abundance of the shRNA sequences was evaluated by
microarray analysis (Fig. 1A). The number of shRNA sequences
that were more than five times more abundant in cells grown
under hypoxia versus normoxia was 2,065 (Fig. 1B). On the other
hand, 20,567 shRNA sequences were five times less abundant in
the same comparison set (Fig. 1B). Since the library includes four
shRNA sequences on average for each gene, we selected genes that
were targeted by four or more shRNA sequences. Consequently,
73 genes satisfied this criterion and 56 of these were confirmed to
be expressed in PC8 cells by RT-PCR analysis (data not shown).
Five genes fell within the ‘‘5-fold overrepresented’’ group and 51
fell within the ‘‘5-fold underrepresented’’ group. A list of these
genes is presented in Table S1.
Figure 1. Genome-wide shRNA screen for genes that regulate
growth in an oxygen-dependent manner. A, Scheme of the
genome-wide shRNA screen. Cells transduced with the shRNA library
were cultured under normoxia or hypoxia until the tenth passage. The
shRNA target sequences were then amplified following reverse
transcription PCR (RT-PCR) of total cellular RNA prepared from the
selected transfectant pools. The identity and relative abundance of the
biotin-labeled shRNA target sequences were evaluated by microarray.
B, Array analysis of shRNA target sequences amplified from RNA
prepared from cells cultured under normoxic or hypoxic selection.
Genes targeted by four or more independent shRNA sequences, and
which exhibited a representation that differed by more than 5-fold
between cells grown under hypoxic and normoxic conditions represent
candidate genes that modulate growth in response to the availability of
oxygen and were studied further.
doi:10.1371/journal.pone.0035590.g001
shRNA Screen of Oxygen-Sensitive Growth Genes
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on cell growth
We next knocked down the expression of the 5 genes in the ‘‘5-
fold overrepresented’’ group by expressing shRNA sequences
targeting each gene using the lentivirus vector system. Knockdown
efficiency of each gene was confirmed by RT-PCR analysis to be
greater than 70% (data not shown). The transfectants were then
cultured under normoxia or hypoxia for seven days. The ratios of
cell growth of the transfectants during hypoxia versus normoxia
were compared to that of the control cells that expressed an
shRNA targeting the luciferase gene (Luc). We observed
a significant increase in the ratio of cell growth during hypoxia
versus normoxia following stable knockdown of GPR68 and
RNF126 with either of two different shRNA sequences, but the
effect of knockdown of the other three genes was not significant
(Fig. 2A). The findings for GPR68 and RNF126 are consistent
with the enrichment of the corresponding shRNA sequences
during the library screening. Even though the relative growth ratio
of the GPR68 and RNF126 knockdown cells between hypoxia
versus normoxia showed a similar increase, there was a differential
effect of the knockdown of each gene on cell growth during
hypoxia and normoxia. Specifically, knockdown of GPR68
increased cell growth during hypoxia but had no effect during
normoxia (Fig. 2B, C), and consequently the relative growth ratio
between cells grown under hypoxia versus normoxia was in-
creased. In contrast, knockdown of RNF126 did not affect cell
growth during hypoxia but inhibited growth during normoxia
(Fig. 2B, C), thus also giving rise to an increase of in the relative
growth ratio.
The knockdown of the other three genes had no significant
effect upon cell growth, but we do not necessarily believe that this
means that these three genes are merely artifacts of the screen.
The cell growth analysis over 7 days represents a much shorter
period of time than that used for the 10-passage screen, and may
be insufficient to observe a measurable effect. Therefore, it is
possible that these genes also play roles in the cellular response to
hypoxia and that they affect the growth of PC8 cells. In contrast, it
is quite clear that GPR68 and RNF126 mediate a greater effect on
cell growth compared to other three genes.
Effect of the genes in the ‘‘5-fold underrepresented’’
group
We next carried out knockdown of the 51 genes selected as the
‘‘5-fold underrepresented’’ group in PC8 cells. Among these,
knockdown of 11 genes (BCL2L1, DDX43, ABTB2, EXOSC9,
CTDSPL, LAMB1, SMCR7L, ERGIC3, PBRM1, TRO, EPRS)
generated cells that exhibited a decreased growth ratio between
hypoxia versus normoxia compared to control cells (Fig. 3A and
4A). The growth ratio of the other knockdown cells was
comparable to that of the control cells (data not shown). The
selected genes could be divided into two groups: One group
comprises genes that decreased cell growth during hypoxia but not
during normoxia following knockdown (Fig. 3B, C), and the other
comprises genes that markedly increased the rate of cell growth
during normoxia, but more modestly during hypoxia following
knockdown (Fig. 4B, C).
Taken together, the products of the 11 genes in the ‘‘5-fold
underrepresented’’ group were confirmed to play roles in the
cellular response to hypoxia and to affect cell growth significantly.
The effect of other selected gene products on cell growth was
negligible at least under the specific conditions of this assay.
Annotation of the identified genes
We queried the REACTOME (www. reactome.org), PAN-
THER (www.pantherdb.org), and KEGG databases (www.
genome.jp/kegg/) to determine whether any of the 13 identified
genes had previously been linked to cellular adaptation to hypoxia
or cell growth. Interestingly, BCL2L1 has an oxygen-sensitive
function. Namely, it encodes an anti-apoptotic Bcl-2 family
protein Bcl-xL that localizes to the mitochondrial outer membrane
and which regulates the opening of an outer membrane channel
and as such plays a role in hypoxia-sensitive apoptosis [21,22].
Figure 2. Identification of oxygen-sensitive genes with in-
creased hypoxia/normoxia growth ratio when knocked-down.
A–C, Confirmatory analysis oxygen-sensitivity of genes indentified in
the genome-wide screen. PC8 cells were transduced with lentiviral
vectors expressing two independent shRNAs targeting each candidate
gene and cultured for one week under normoxia or hypoxia. The
resulting hypoxia/normoxia growth ratio (A) and cells numbers when
cultured during normoxia (B) or hypoxia (C) were analyzed. In A–C,
error bars indicate s.d. (n=3) and the data were analyzed by the t-test.
*p,0.05, **p,0.01.
doi:10.1371/journal.pone.0035590.g002
shRNA Screen of Oxygen-Sensitive Growth Genes
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hypoxia related functions.
We next carried out a Gene Ontology analysis of the genes by
taking advantage of the AmiGO database (http://amigo.
geneontology.org) so as to obtain information about the sub-
cellular localizations of their products. As listed in Table 1, the
gene products are likely to localize to the nucleus, cytosol,
mitochondria, ER/Golgi, plasma membrane, and extracellular
compartments. However, there was no information available for
the CTDSPL and RNF126 gene products, so we used data from the
PSORT database (psort.hgc.jp) to predict their subcellular
localizations. Both products were predicted to localize to the
nucleus. Proteins encoded by GPR68, LAMB1, and TRO are likely
to localize to the plasma membrane and may face the extracellular
space.
We next analyzed the annotated biological functions of the
identified genes (Table 1, biological process). A role in cell growth
and proliferation was annotated to 6 genes, which seems
reasonable since the genes were identified based on a screen for
oxygen-sensitive cell growth. A role in the immune/inflammation
response was annotated to three genes (BCL2L1, EXOSC9,
GPR68). As inflammatory sites tend to be hypoxic, these functions
Figure 3. Knockdown of the genes decreased hypoxia/
normoxia growth ratio due to reduced growth during hypoxia.
A–C, Confirmatory analysis of the oxygen-sensitive genes was
performed as described in Figure 2. The resulting hypoxia/normoxia
growth ratio (A) and cell numbers when cultured during normoxia (B)
or hypoxia (C) were analyzed. In A–C, error bars indicate s.d. (n=3) and
the data were analyzed by the t-test. *p,0.05.
doi:10.1371/journal.pone.0035590.g003
Figure 4. Knockdown of the genes decreased hypoxia/
normoxia growth ratio due to increased growth during
normoxia. A–C, Confirmatory analysis of the oxygen-sensitive genes
was performed as described in Figure 2. The resulting hypoxia/
normoxia growth ratio (A) and cell numbers when cultured during
normoxia (B) or hypoxia (C) were analyzed. In A–C, error bars indicate
s.d. (n=3) and the data were analyzed by the t-test. *p,0.05, **p,0.01.
doi:10.1371/journal.pone.0035590.g004
shRNA Screen of Oxygen-Sensitive Growth Genes
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during inflammation.
We also explored the annotated molecular functions of the
genes (Table 1, molecular function). Protein binding was
annotated to six genes and nucleotide binding to either RNA
and/or DNA was annotated to five genes, including DDX43,
EXOSC9, EPRS, ABTB2, PBRM1. Products of these genes may
play roles in regulating translation/transcription during the
cellular response to stress.
Identified genes are not inducible during hypoxia
The increased activity of HIF transcription factors during
hypoxia induces the expression of many genes whose products play
a role in the adaptation to hypoxia. Indeed, a marked increase in
the expression of the HIF-1a protein was observed in PC8 cells
cultured for 24 hrs in hypoxic conditions (Fig. 5A). Therefore, it is
possible that the expression of the genes selected by the screening
is also affected by hypoxia at the transcription level. To evaluate
this, we examined the expression of the mRNAs transcribed from
the 13 genes during normoxia and hypoxia by quantitative RT-
PCR. The mRNAs encoding the representative HIF-1 target
genes, GLUT1 and PDK1 [23–25], were increased approximately
by seven and four fold respectively over that observed during
normoxia (Fig. 5B). In contrast, none of the 13 identified genes
exhibited significantly altered expression during hypoxia (Fig. 5B).
Thus, our screening method successfully identified a new class of
genes that play roles in the cellular response to hypoxia and which
modulate cell growth, but which are not regulated at the level of
transcription in a hypoxia-dependent manner.
Discussion
In this study, we sought to identify genes that play roles in the
cellular response to hypoxia. We carried out genome-wide gene
knockdown screening using an shRNA library. Target genes that
affect cell growth differentially during hypoxia and nomoxia were
selected. We identified 73 genes whose mRNAs were targeted by
at least four independent shRNA sequences in the library, and
whose representation within the selected cell populations exhibited
at least a five-fold change between cells grown under normoxia
versus hypoxia. Fifty-six of these genes were confirmed to be
expressed in PC8 cells, and knockdown of 13 of these genes indeed
affected cell growth significantly in an oxygen-dependent manner.
Cells depleted for the expression of each identified gene using
cognate shRNAs exhibited an approximate 20% difference in the
rates of growth when cultured under normoxic versus hypoxic
conditions. These effects were significant and reproducible,
supporting the screening results. Surprisingly, none of the 13
identified genes is a target of HIF-1 as their expression was not
increased during hypoxia (Fig. 5B). However, this result does not
necessarily means that HIF-1 and its target genes are not required
for the oxygen-sensitive cell growth. Indeed, we detected three or
less shRNA sequences for HIF1A and HIF-1 target genes such as
GLUT1 and PDK1 in the list of shRNA screening described in
Fig. 1A. Thus, our very stringent selection criteria, namely four or
more shRNA sequences for a gene, eliminated HIF-1 and its target
genes. This also means that we can identify more genes that
potentially regulate the oxygen-sensitive cell growth if stringency of
selection criteria was lowered.
The proteins encoded by the 13 genes are possible regulators of
the cellular response to hypoxia and consequently affect cell
growth. Although these genes have not been implicated in cell
growth regulation directly, it will be necessary to identify the
reported functions of the gene products before exploring the exact
mechanism of the effect of each gene during hypoxia. It is
particularly important that the identified genes include BCL2L1,
which encodes a member of the Bcl-2 protein family and is
expected to contribute to cell survival during hypoxia by
preventing apoptosis [21,22]. Therefore, we think the identifica-
tion of BCL2L1 validates our screening method and suggests that
the conditions applied were appropriate to enrich for the genes we
intended. We also speculate that the other gene products may play
Table 1. Gene ontology analysis of the identified oxygen-sensitive growth regulator genes.
Component:
Nucleus BCL2L1, DDX43, EXOSC9, CTDSPL, PBRM1, TRO
Cytosol BCL2L1, DDX43, EXOSC9, TRO, EPRS
Mitochondrion BCL2L1, SMCR7L
ER/Golgi ERGIC3
Plasma membrane TRO, GPR68
Extracellular region LAMB1
Unknown ABTB2, RNF126
Biological process:
Growth/proliferation (both positively or negatively) ABTB2, BCL2L1, EXOSC9, LAMB1, PBRM1, TRO,
Immune/inflammation response BCL2L1, EXOSC9, GPR68
Adhesion LAMB1, TRO
Molecular function:
Protein binding BCL2L1, EXOSC9, LAMB1, SMCR7L, PBRM1, EPRS, RNF126
RNA binding DDX43, EXOSC9, EPRS
DNA binding ABTB2, PBRM1
ATP binding DDX43, EPRS
Metal ion binding CTDSPL, RNF126
Categories of biological processes and molecular functions represented by at least two genes are listed.
doi:10.1371/journal.pone.0035590.t001
shRNA Screen of Oxygen-Sensitive Growth Genes
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to cell growth. GPR68 encodes a G protein-coupled receptor that
binds protons and acts as an extracellular pH sensor [26,27]. Since
hypoxia promotes lactate production via glycolysis, GPR68 may
act to sense the acidic extracellular environment so as to transduce
a proton-mediated signal to the cell growth machinery. DDX43,
EXOSC9, CTDSPL, and EPRS genes have been implicated in RNA
metabolism [28–31]. Because the expression of mRNAs encoding
many genes must change to adapt to hypoxia, such as those
regulated by HIF transcription factors, the identified genes that
encode proteins involved in RNA metabolism might play roles in
the transcriptional and/or translational regulation of genes during
the adaptation to hypoxia. CTDSPL has been implicated as a tumor
suppressor gene, and its expression is suppressed or lost in many
cancer cell lines [29,32,33]. However, CTDSPL is expressed in
PC8 cells and has a growth-promoting effect during hypoxia
(Fig. 3C). As the function of the CTDSPL gene product remains
unclear, further analyses of CTDSPL will be necessary to solve the
apparent contradiction between our findings and the reported
tumor suppressor function.
In addition to PC8 cells, we examined whether the identified 13
genes also affect the oxygen-sensitive cell growth in another cell
line, invasive breast cancer MDA-MB-231 cells (Fig. S1). All genes
except ABTB2 and DDX43 affected the oxygen-sensitive growth of
MAD-MB-231 cells like PC8 cells. DDX43 was not expressed in
MDA-MB-231 cells, whereas ABTB2 was expressed. Thus, it is
plausible that roles of the identified genes contribute to the
oxygen-sensitive growth in a cell-context dependent manner.
In summary, we have identified a new class of genes involved in
the cellular response to hypoxia using a genome-wide shRNA
library-based screen. Identification and analysis of the products of
the genes identified by this screen should eventually expand our
understanding of the changes in cellular physiology in cells
exposed to hypoxic conditions and may provide clues for
therapeutic targets to treat diseases where hypoxia plays an
important role in the pathophysiology, such as brain and heart
infarction, diabetic gangrene, chronic inflammatory disease, and
cancer.
Materials and Methods
Cell culture
Human lung adenocarcinoma PC8 cells [34] were kindly gifted
from National Cancer Center (Tokyo, Japan). Human breast
cancer MDA-MB-231 cells were purchased from ATCC. Cells
were cultured in RPMI (PC8) or DMEM (MDA-MB-231)
containing 10% fetal bovine serum, 100 units/mL penicillin,
and 100 mg/mL streptomycin (Sigma) at 37uC in a humidified 5%
CO2 environment. For experiments conducted under hypoxic
conditions, cells were cultured in a 1% O2 and 5% CO2
environment in a Model 9200 incubator (Wakenyaku).
RNAi screening
GeneNet
TM Lentiviral shRNA Libraries Human 50 K (System
Biosciences) were introduced into PC8 cells according to the
manufacture’s instruction. Library cells were cultured under
normoxia or hypoxia until the tenth passage. The shRNA
templates were recovered from the selected cells by RT-PCR
and analyzed using Affymetrix GeneChipH Arrays according to
the manufacture’s instruction.
Vector construction
The shRNA sequences used in this study are listed in Table S2.
The deoxyribose versions of the targeted gene sequences were
subcloned into pENTR/U6 TOPO (Invitrogen) before being
transferred via recombination into the lentivirus vector, pLenti6
BLOCKi (Invitrogen).
Cell growth assay
Cells (1610
4) were seeded onto a plastic dish and cultured at
37uC in a humidified CO2 incubator. The cells were counted
periodically using a Coulter counter (Beckman).
Western blot analysis
Cells were lysed with lysis buffer and centrifuged at 20,000 g for
15 minutes at 4uC. The supernatants were collected and total
protein content measured using the Bradford assay (Bio-Rad).
Lysates were separated by SDS-PAGE, transferred to membrane
Figure 5. The identified oxygen-sensitive growth regulator genes that are not differentially expressed during hypoxia. A, Western
blot analysis of actin and HIF-1a in normoxic and hypoxic cells. HIF-1a serves as an indicator of the hypoxic response. B, RT-PCR analysis of HIF-1
target genes and the identified oxygen-sensitive growth regulator genes. The expression of each gene was normalized to that of beta-actin. GLUT1
and PDK1 are representatives of HIF-1 target genes.
doi:10.1371/journal.pone.0035590.g005
shRNA Screen of Oxygen-Sensitive Growth Genes
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antibody (Millipore) or anti-HIF-1a mouse antibody (BD Bios-
ciences).
RNA isolation, reverse transcription and real-time PCR
Total RNA was isolated from cells using TRIzol reagent
(Invitrogen) and subjected to reverse transcription (RT) using
SuperscriptII (Invitrogen) and random primers. The RT products
were then subjected to real-time PCR in a Smart Cycler II System
(Cepheid) using SYBR GREEN I (BioWhittaker Molecular
Applications) and the specific primers for each gene (Table S3).
The PCR products were sequenced and their homogeneity was
confirmed by dissociation temperature monitoring of SYBR
GREEN I fluorescence.
Statistical analysis
We compared two subject groups by the two-sided t-test.
Supporting Information
Figure S1 Knockdown of the identified oxygen-sensitive
genes affected hypoxia/normoxia growth ratio in MDA-
MB-231 cells. The hypoxia/normoxia growth ratio in MDA-
MB-231 cells was analyzed as described in Figure 2. Error bars
indicate s.d. (n=3) and the data were analyzed by the t-test.
*p,0.05. N.D.; not detected.
(PDF)
Table S1 List of ‘‘5-fold overrepresented’’ and ‘‘5-fold
under represented’’ groups.
(PDF)
Table S2 shRNA sequences used in this study.
(PDF)
Table S3 Primer sequences used in this study.
(PDF)
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